title: Using CD40 ligand expression to detect antigen-specific T cells in patients with drug eruptions.
authors.affiliation: Department of Dermatology, Sakura Medical Center, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-8741, Japan. higuchit@sakura.med.toho-u.ac.jp.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Higuchi
authors.forename: Takahiro
authors.initials: T
authors.lastname: Satoh
authors.forename: Hiroo
authors.initials: H
authors.lastname: Yokozeki
mesh_terms: D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects; D015415:Biomarkers / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D023201:CD40 Ligand / Q000378:metabolism*; D002220:Carbamazepine / Q000009:adverse effects; D002478:Cells, Cultured; D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D010634:Phenobarbital / Q000009:adverse effects
chemical_list: D000927:Anticonvulsants; D015415:Biomarkers; D023201:CD40 Ligand; D002220:Carbamazepine; D010634:Phenobarbital